Chemistry and pharmacological aspects of furanoid cannabinoids and related compounds: Is furanoid cannabinoids open a new dimension towards the non-psychoactive cannabinoids?

Eur J Med Chem. 2024 Mar 15:268:116164. doi: 10.1016/j.ejmech.2024.116164. Epub 2024 Feb 9.


Cannabinoids have emerged as compelling candidates for medicinal applications, notably following the recent approval of non-psychoactive cannabidiol (CBD) as a medicine. This endorsement has stimulated a growing interest in this class of compounds for drug discovery. Within the cannabis plant, a rich reservoir of over 125 compounds exists. Tetrahydrocannabinol (THC), a member of the dibenzopyran class, is widely recognized for its psychoactive effects. Conversely, the furanoid class, represented by cannabielsoin-type (CBE) and cannabifuran-type (CBF) compounds, has not been reported with psychoactivity and demonstrates a spectrum of pharmacological potential. The transition from the pyran structure of THC to the furan structure of CBE seems to mark a shift from psychoactive to non-psychoactive properties, but a comprehensive examination of other members in this class is essential for a complete understanding. Building on these observations, our thorough review delves into the subject, offering a comprehensive exploration of furanoid cannabinoids, covering aspects such as their biosynthesis, classification, synthesis, and medicinal potential. The aim of this review is to encourage and catalyze increased research focus in this promising area of cannabinoid exploration.

Keywords: Cannabielsoin; Cannabinoids; Cannabis; Furaniod; Non-psychoactive.

Publication types

  • Review

MeSH terms

  • Cannabidiol* / analogs & derivatives*
  • Cannabinoids* / pharmacology
  • Cannabis* / chemistry
  • Dronabinol / pharmacology


  • Cannabinoids
  • cannabielsoin
  • Cannabidiol
  • Dronabinol